Histone deacetylase inhibitor LBH589 radiosensitizes non-small cell lung cancer by inhibiting DNA repair

被引：0
|
作者：
Cuneo, K. C. [1 ]
Fu, A. [1 ]
Hallahan, D. E. [1 ]
Geng, L. [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.314
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1049
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [41] The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
    Woods, David M.
    Woan, Karrune
    Cheng, Fengdong
    Wang, Hongwei
    Perez-Villarroel, Patricio
    Lee, Calvin
    Lienlaf, Maritza
    Atadja, Peter
    Seto, Edward
    Weber, Jeffrey
    Sotomayor, Eduardo M.
    Villagra, Alejandro
    MELANOMA RESEARCH, 2013, 23 (05) : 341 - 348
  • [42] The histone deacetylase inhibitor LBH589 inhibit undifferentiated pleomorphic sarcoma growth via downregulation of FOSL1
    Saitoh, Yoshinobu
    Setoguchi, Takao
    Nagano, Satoshi
    Taniguchi, Noboru
    CANCER SCIENCE, 2018, 109 : 1416 - 1416
  • [43] A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies.
    Moore, A. P.
    Thomas, S.
    Ryan, C. J.
    Jahan, T. M.
    DuBois, S. G.
    Chan, J. K.
    Thurn, K. T.
    Collisson, E. A.
    Reinert, A.
    Daud, A.
    Munster, P. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Histone Deacetylase Inhibitor LBH589 (Panobinostat) Suppresses the Activated-NFκB Pathway in Acquired Aromatase Inhibitor Resistant Breast Cancer Cells
    Kubo, M.
    Kanaya, N.
    Liu, Z.
    Chen, S.
    CANCER RESEARCH, 2011, 71
  • [45] A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies.
    Moore, Amy Patricia
    Thach-Giao Truong
    Thurn, Kenneth Ted
    Thomas, Scott
    Ryan, Charles J.
    Jahan, Thierry Marie
    DuBois, Steven G.
    Chan, John K.
    Rugo, Hope S.
    Collisson, Eric Andrew
    Raha, Paromita
    Chen, Stephanie
    Reinert, Anne
    Daud, Adil
    Munster, Pamela N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Antitumor effects of a novel histone deacetylase inhibitor (chidamide) on non-small cell lung cancer cell lines
    Han, X.
    Zhang, N.
    Yao, J.
    Shi, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S41 - S41
  • [47] c-FLIP Degradation Mediates Sensitization of Pancreatic Cancer Cells to TRAIL-Induced Apoptosis by the Histone Deacetylase Inhibitor LBH589
    Kauh, John
    Fan, Songqing
    Xia, Mingjing
    Yue, Ping
    Yang, Lily
    Khuri, Fadlo R.
    Sun, Shi-Yong
    PLOS ONE, 2010, 5 (04):
  • [48] The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells
    Scuto, Anna
    Kirschbaum, Mark
    Kowolik, Claudia
    Kretzner, Leo
    Juhasz, Agnes
    Atadja, Peter
    Pullarkat, Vinod
    Bhatia, Ravi
    Forman, Stephen
    Yen, Yun
    Jove, Richard
    BLOOD, 2008, 111 (10) : 5093 - 5100
  • [49] Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer
    Denlinger, CE
    Keller, MD
    Mayo, MW
    Broad, RM
    Jones, DR
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (04): : 1078 - 1086
  • [50] Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity.
    Toshimitsu, T
    Munshi, A
    Hobbs, M
    Meyn, RE
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9027S - 9028S
12345